Related Experiment Videos
Prognostic factors in thymic epithelial tumors undergoing complete resection
Charalambos Zisis1, Dimitra Rontogianni, Chara Tzavara
1Department of Thoracic Surgery and Pathology, Evangelismos Hospital, Athens, Greece. chzisis@otenet.gr
The Annals of Thoracic Surgery
|August 27, 2005
Summary
Tumor recurrence, Masaoka stage, World Health Organization (WHO) histologic type, and patient age are key prognostic factors for thymic epithelial tumors (TET) after complete resection. These findings aid in predicting patient outcomes and guiding treatment strategies for TET.
Area of Science:
- Oncology
- Thoracic Surgery
- Pathology
Background:
- Investigated prognostic factors in thymic epithelial tumors (TET) over 27 years.
- Included 104 patients with complete resection of TET, mean age 53 years.
Purpose of the Study:
- Identify key prognostic factors for TET patients undergoing complete resection.
- Determine variables influencing short-term and long-term survival.
Main Methods:
- Retrospective review of medical records for 104 TET patients.
- Cox regression analysis to assess six potential prognostic variables.
- Follow-up until September 2004 or patient death.
Main Results:
- Overall 5-year and 10-year survival rates were 83% and 78%.
- Univariate analysis identified age, myasthenia gravis response, recurrence, WHO histologic type, and Masaoka stage as significant factors.
- Multivariate analysis highlighted tumor recurrence, Masaoka stages II/III, elder age, and WHO histologic types B2/B3 as negative prognosticators.
Conclusions:
- Tumor recurrence, Masaoka staging, WHO histologic type, and patient age are critical prognosticators for TET.
- These factors are crucial for predicting outcomes in completely resected TET.
- Findings support refined risk stratification and personalized treatment approaches for TET.